Cannabis as Medicine

  Mounting scientific evidence continues to challenge the narrative that cannabis is a harmless substance, with alarming new research demonstrating significant THC effects on fertility and embryonic development. A groundbreaking study conducted by researchers in Canada and Israel has uncovered disturbing links between THC exposure and chromosomal abnormalities in human embryos created through IVF. The

The American College of Obstetricians and Gynaecologists (ACOG) has issued decisive new clinical guidance declaring there is no safe level of marijuana during pregnancy and recommending universal screening for cannabis use throughout pre-pregnancy, pregnancy, and postpartum periods. The authoritative medical organisation’s statement directly challenges the increasingly prevalent misconception that cannabis represents a safe or beneficial

This document addresses three of the TGA (Therapeutic Goods Administration) 2025 consultation questions: 1. Contraindications for medical cannabis – see Appendix A 2. Claims for medical cannabis not supported by rigorous science – See Appendix B 3. Lack of quality assurance in the production of medicinal cannabis – See Appendix C   View Document

Australia’s medicines regulator has not investigated the safety of most medicinal cannabis products despite receiving hundreds of “adverse event” reports ranging from coughing to psychosis in the past three years. The ABC can reveal there were 615 reports made to the Therapeutic Goods Administration (TGA) involving unregistered medicinal cannabis products between July 1, 2022 and

  New research from the University of California San Diego School of Medicine reveals that people with cannabis use disorder face more than triple the risk of developing oral cancer within five years. Furthermore, the study analysed electronic health records from over 45,000 patients and found that cannabis linked to oral cancer represents a significant

Growing evidence suggests that cannabis immunotherapy risks may significantly compromise cancer treatment outcomes, according to a comprehensive new review by Australian medical cannabis advocate Dr Ben Jansen. Furthermore, his research poses a critical question that could reshape patient care protocols: “Are cannabinoids with cancer immunotherapy contributing to early death?” Subsequently, Dr Jansen’s newly published study